SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " trial " 1,387 found 🔀 AI-powered Shuffle
Zap in a cap: How one neurotech startup is using a hat to treat depression
FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat depression.
I’m a fourth-year med student, but I only learned one historical example of medical racism
Modern randomized controlled trials often rely on marginalized populations abroad.
Be part of the region’s real estate momentum
Special Promotion Four out of five of Business Report’s most-read stories focus on real estate—spanning commercial, residential, and industrial sectors. It’s a clear signal that our business community is actively seeking insight into the growth shaping the Capital Region. That’s why our June Real Estate issue remains one of Business Report’s most in-demand editions, spotlighting […]
How to Watch Watson Season 2, Episode 19
Watch Watson live with TV channel, start time and streaming info. Stream Season 2, Episode 19 on Fubo — no cable required, free trial available.
How to Watch Bob's Burgers Season 16, Episode 11
Watch Bob's Burgers live with TV channel, start time and streaming info. Stream Season 16, Episode 11 on Fubo — no cable required, free trial available.
How to Watch American Dad! Season 20, Episode 6
Watch American Dad! live with TV channel, start time and streaming info. Stream Season 20, Episode 6 on Fubo — no cable required, free trial available.
How to Watch Y: Marshals Season 1, Episode 9
Watch Y: Marshals live with TV channel, start time and streaming info. Stream Season 1, Episode 9 on Fubo — no cable required, free trial available.
Trials season 4: What’s on the horizon
ARC Raiders is a multiplayer extraction adventure, set in a lethal future earth, ravaged by a mysterious mechanized threat known as ARC.
There Are 45 Earth-Like Worlds Where Aliens May Exist, Scientists Say
Scientists identify 45 potentially habitable exoplanets, using exact data and quotes to guide future telescopes in the search for extraterrestrial life.
FDA grants quick review for 3 psychedelic drug trials
FDA commissioner Marty Makary told NBC News that the first psychedelic drug could be approved in the U.S. as soon as this summer.
SQUARE ENIX ANNOUNCES <em>EVERCOLD—</em><br /> LATEST <em>FINAL FANTASY XIV </em>EXPANSION SET FOR<br /> JANUARY 2027
EVANGELION Crossover Alliance Raid and Nintendo Switch 2 Version Revealed; Shadowbringers Expansion Added to Free Trial and More
Marshall Health Network enrolling patients in lung cancer clinical trial evaluating personalized immunotherapy approach
lungllulungHUNTINGTON, W.Va. – The Edwards Cancer Institute at Marshall Health Network (MHN) is enrolling eligible patients in a clinical trial evaluating whether a personalized immunotherapy approach can enhance the effectiveness of treatment following lung cancer surgery. The study is investigating the use of an individualized therapy designed with a tumor’s unique biology from a surgical sample to help the immune system better […]
3 more men convicted of homicide in fatal shooting of Pontiac business owner
White House accuses China of 'industrial-scale' AI technology theft weeks ahead of Trump-Xi summit
The White House OSTP accuses China of running industrial-scale distillation campaigns to steal American AI technology ahead of the Trump-Xi summit.
Vanderbilt Health implants novel device to treat aortic regurgitation in high-risk patients
With the addition of the J-Valve device, Vanderbilt Health now offers minimally invasive procedures to implant devices treating every valve disease. The trial is still enrolling new patients, so other high-risk patients with aortic regurgitation could qualify.
UK packaging maker to build up e-commerce business at Clinton Commerce Center
There were no presses left to stop for the news announced at the huge industrial building at 2201 Sweeney Dr. within Clinton Commerce Center in Findlay Township.
Quick look at the best read Tri-Cities business stories this week
From a major tax break proposal in Pasco to a new rail deal at Big Pasco Industrial Park, it was a busy week for business and community news in the Tri-Cities.
American Industrial Partners to Acquire Honeywell's Warehouse and Workflow Solutions Business
/PRNewswire/ -- American Industrial Partners ("AIP"), an operationally oriented industrials investor, today announced that a fund managed by it has signed a...
In Hazelwood, a field of dreams
On the eve of the NFL Draft, Pittsburgh officials, community leaders and student athletes gathered Wednesday on the site of a former industrial facility...
Meet Jenni Peters, one of the Capital Region 500
Jenni Peters, a former USA Track & Field athlete and a competitor in the first-ever Olympic Marathon Trials in 1984, turned her passion for running into a thriving business. She launched Varsity Sports in 2000 near the Perkins Road overpass, growing it into a beloved local chain with four locations. The stores, often set in […]
Using AI To Personalize Healthcare–Without Losing Patient Trust
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.
Scientists discovered a mysterious ‘golden orb’ two miles beneath the surface of the ocean. Now they’ve worked out what it is
Sorry, but it’s not an extraterrestrial egg...
Are cancer-screening blood tests close to prime time?
Earlier this year, the largest trial to date on cancer blood tests failed to reach its primary objective. Oncologists haven't lost hope.
5 semi-trucks burn outside New Smyrna Beach business
The New Smyrna Beach Fire Department said it happened Sunday night at Reddy Ice off Industrial Park Avenue.
Honeywell Said Close to Selling Unit to Brady for $1.4 Billion
Honeywell International Inc. is nearing a deal to divest its productivity solutions and services business to industrial manufacturer Brady Corp., according to people familiar with the matter.
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s Trial
Researchers are exploring whether GLP-1 medications used for diabetes and weight loss could treat Alzheimer’s and addiction.
How To Watch From Season 4 Premiere
Watch From live with TV channel, start time and streaming info. Stream Season 4 Premiere on Fubo — no cable required, free trial available.
Grand Rounds April 10, 2026: Impact of Behavioral Science-Based Electronic Health Record Tools on Deprescribing for Older Adults (Julie Lauffenburger, PharmD, PhD)
Speaker Julie Lauffenburger, PharmD, PhD Associate Professor of Medicine Brigham and Women’s Hospital and Harvard Medical School Keywords Adaptive trial design; Behavioral science; Deprescribing; electronic health record; EHR; Inappropriate […]
Grand Rounds April 10, 2026: Impact of Behavioral Science-Based Electronic Health Record Tools on Deprescribing for Older Adults (Julie Lauffenburger, PharmD, PhD)
Speaker Julie Lauffenburger, PharmD, PhD Associate Professor of Medicine Brigham and Women’s Hospital and Harvard Medical School Keywords Adaptive trial design; Behavioral science; Deprescribing; electronic health record; EHR; Inappropriate […]
Lake State Railway, TGS Cedar Port receive ASLRRA Business Development Awards
MINNEAPOLIS — Lake State Railway and TCS Cedar Port, a Texas industrial park which operates its own short line, were honored with Business Development Awards at the recent American Short Line and Regional Railroad annual conference. Also honored on the conference’s final day was Gary Vaughn, recipient of the ASLRRA’s Schlosser Distinguished Service Award. Lake State Railway was recognized for its work
Pancreatic cancer mRNA vaccine shows lasting results in an early trial
Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.
Experimental drug doubles one-year survival in pancreatic cancer
A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.
Opening statements set for Tuesday in Harvey Weinstein's rape retrial
Opening statements are set for Tuesday in Harvey Weinstein’s third trial on a New York rape charge. Four days of jury selection wrapped up Friday. A jury of seven men
Spare tire outside business leads to assault charges in Brook Park
Police arrested a Fairview Park man April 6 after he attacked a Cleveland man outside a multitenant industrial-office building on Brookpark Road.
The Science Of Taper As Preparation For Swim Performance
After months of research, Cooper Gill found that taper matters more than most people think, and the biggest factor isn’t fitness, it’s fatigue.
Apple Could Unveil Its Sub-1nm Chips In A Few Years, As TSMC Said To Fire Up Trial Production In 2029
A report states that TSMC is planning to begin trial production of its sub-1nm process in 2029, giving Apple an opportunity to unveil a technological marvel
Why Promising Cancer Drugs Failed: Scientists Uncover the Missing Piece
A new study helps explain why a promising class of cancer drugs has often failed to meet expectations in clinical trials.
Thousands suffer nausea, delirium and other health issues from toxins in the Tijuana River
For decades, billions of gallons of sewage and industrial waste have been dumped into the Tijuana River.
Tijuana River sewage is making the air toxic, scientists say
For decades, billions of gallons of sewage and industrial waste have been dumped into the Tijuana River.
Railmark announces return to passenger rail business
HENDERSON, Ky. — Railmark Holdings, which operates short lines and provides industrial switching along with a number of other rail services, is returning to the passenger rail business through subsidiary Train Travel Inc., the company announced on Wednesday, April 15. Train Travel’s 38-year history includes operation of the Star Clipper Dinner Train and Reno Fun Train, as well as a rail-centric
MIT scientists just found a hidden problem slowing the ozone comeback
The ozone layer has been on track to recover thanks to the Montreal Protocol—but a loophole may be holding it back. Chemicals still permitted for industrial use are leaking into the atmosphere at higher rates than expected. Scientists now estimate this could delay ozone recovery by up to seven years. Closing this gap could speed up healing and reduce harmful UV exposure worldwide.
Aliens exist! Steven Spielberg shows off 'Disclosure Day' extraterrestrials at CinemaCon
Steven Spielberg showed off the first glimpses of aliens from his new UFO thriller 'Disclosure Day' at CinemaCon on Wednesday during Universal Pictures' panel.
Scientists solve 100-year-old mystery behind rubber that powers modern life
Every time you drive, board a plane or water your lawn, you're relying on a material that has quietly powered modern life for nearly a century—reinforced rubber. It's in car and aircraft tires, industrial ...
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
Tivoxavir marboxil advancing towards a human influenza challenge trial as a once-monthly prophylactic agent, building on broad preclinical antiviral activity, Ratutrelvir topline Phase 2a data show a differentiated profile versus PAXLOVID® in COVID patients, with good overall safety; final study analysis underway Private financing of up to $60M (with $10M of such amount upfront) offering of common stock and milestone-based and three-year warrants completed on April 15, 2026 supporting operations
Live Nation found liable liable in antitrust trial
The Justice Department and 39 states sued Live Nation to split the entertainment giant from Ticketmaster, calling it an illegal monopoly.
Trial date set for suspects in Kansas City sports reporter’s death
A trial date has been set for the three suspects in connection to a Kansas City sports reporter's death.
Re:Cognition Health Delivers Landmark International Clinical Trial to Explore Whether a Simple Finger-prick Blood-based Biomarker Test Can Provide Earlier Alzheimer's Diagnosis
Re:Cognition Health, a global leader in new treatments for Alzheimer's Disease, is delivering an international clinical trial to evaluate whether a simple finger-prick blood test can revolutionize how Alzheimer's disease is diagnosed. Compared with the current invasive and expensive diagnostic methods, this approach could provide a scalable solution for an earlier, easier, more accurate, affordable, and accessible diagnostic method. Re:Cognition Health will help enroll approximately 1,000 partic
Jury selection starts for Harvey Weinstein's latest retrial in N.Y. rape case
It's the third time that jurors will weigh whether he raped a woman.
UT Health San Antonio Multispecialty and Research Hospital treats first clinical trial participant in novel cancer study - UT Health San Antonio
Milestone paves the way for advancements in cancer care, innovation and patient care in San Antonio and South Texas Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content by Jane Alvarez-Hernandez SAN ANTONIO, April 15, 2026 – UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer […]
'Industrial' clickbait disinformation targets Australian politics
From anti-transgender narratives about Olympic swimmers to
'Industrial' clickbait disinformation targets Australian politics
From anti-transgender narratives about Olympic swimmers to
A new way to detect life beyond Earth without knowing what life looks like
Researchers from the Earth-Life Science Institute (ELSI) and National Institute for Basic Biology have developed a new method to detect extraterrestrial life without relying on traditional biosignatures. By modelling how life might spread between planets, they demonstrate that life could be detected through statistical patterns across planetary populations rather than on individual planets. This "agnostic biosignature" approach could assist in guiding future searches for life beyond Earth.
Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain
Human trials on the hybrid sensor are expected to begin in the years ahead.
Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain
Human trials on the hybrid sensor are expected to begin in the years ahead.
Q&A with chemist Max Delferro: Unlocking breakthroughs in catalytic science
In this Q&A, chemist Max Delferro explains how his team is combining catalysis, artificial intelligence and robotics to speed chemical discovery — cutting catalyst development from decades to years while advancing more efficient industrial processes.
Q&A with chemist Max Delferro: Unlocking breakthroughs in catalytic science
In this Q&A, chemist Max Delferro explains how his team is combining catalysis, artificial intelligence and robotics to speed chemical discovery — cutting catalyst development from decades to years while advancing more efficient industrial processes.
Harvey Weinstein is going on trial again in a New York rape case
Harvey Weinstein is going on trial again on a rape charge in New York City, after years of #MeToo infamy, legal peril and prison | KCBS All News 106.9FM and 740AM
Harvey Weinstein is going on trial again in a New York rape case
Harvey Weinstein is going on trial again on a rape charge in New York City, after years of #MeToo infamy, legal peril and prison | 104.1 FM KMOX
Fastenal CEO says business has been ‘slowly ramping up’ since last summer
Fastenal CEO Dan Florness joins 'Money Movers' to discuss an uptick in industrial production, tariff impacts, and more.
Baker Hughes sells Waygate unit to Hexagon for about $1.45 billion
Oilfield services provider Baker Hughes sold its Waygate Technologies unit to Swedish industrial technology group Hexagon for about $1.45 billion in cash, the two companies said on Monday.
How to Watch Y: Marshals Season 1, Episode 7
Watch Y: Marshals live with TV channel, start time and streaming info. Stream Season 1, Episode 7 on Fubo — no cable required, free trial available.
Prep talk: Arcadia Invitational is set for Saturday at Arcadia High
Olympian Quincy Wilson leads the athletes scheduled to compete at the Arcadia Invitational in the night portion at 5 p.m.
Manipulating Science, Manipulating Us
Four decades ago, I and Gerald Markowitz published an article in the American Journal of Public Health that attracted a fair amount of attention. The article was about the history of the introduction of tetraethyl lead into gasoline in the 1920s. The article detailed the controversy over putting lead, even then a known industrial poison and neurotoxin, into the gasoline that was powering the new automobile, particularly those that were produced by the General Motors Company.
Jury starts deliberating states’ claim that Live Nation has a monopoly on concerts and ticketing
States argue Live Nation and Ticketmaster are driving up prices to see live music.
Jury starts deliberating states' claim that Live Nation has monopoly on concerts
Soon after starting deliberations the jury in Manhattan federal court told the judge it wanted to review certain testimony given at the five-week trial
Jury starts deliberating states' claim that Live Nation has a monopoly on concerts and ticketing
Jury deliberations have begun in a civil case pitting 34 states against the concert giant Live Nation Entertainment | 1080 WTIC NEWSTALK
Live Nation antitrust trial nears end as lawyer for 34 states labels the concerts giant a monopolist
A lawyer for states suing Live Nation Entertainment has tried to convince a jury during an antitrust trial's closing arguments that the company and its ticketing arm, Ticketmaster, are monopolizing...
Health Physicists: The Quiet Experts Keeping Radiation Risks in Check
When radioactive materials are involved, whether at a former nuclear weapons site, a decommissioned reactor, or a legacy industrial facility, the goal is simple: protect workers, safeguard communities and reduce potential radiation risks to levels that are demonstrably safe. At the U.S. Army Corps of Engineers (USACE), health physicists are the professionals responsible for making that happen. Their work is often behind the scenes but always with consequences that matter deeply to the public.
Sean 'Diddy' Combs' lawyers appeal his conviction with First Amendment argument
Sean “Diddy” Combs’ lawyers are poised to try to persuade federal appeals court judges that the hip-hop mogul was treated unfairly at a trial last year that sent him to prison on prostitution-related charges | KNX News 97.1 FM
Sean 'Diddy' Combs' lawyers appeal his conviction with First Amendment argument
Sean “Diddy” Combs’ lawyers are poised to try to persuade federal appeals court judges that the hip-hop mogul was treated unfairly at a trial last year that sent him to prison on prostitution-related charges | KYW Newsradio
Atkore Inc. Announces Sale of HDPE Pipe & Conduit Business to Infra Pipes
Atkore Inc. (the “Company”) (NYSE: ATKR), a leading manufacturer of electrical products for commercial, industrial, data center, and solar applications, toda...
April 8, 2026: Behavioral Science-Based Electronic Health Record Tools, in This Week's Rethinking Clinical Trials Grand Rounds
In this Friday’s Rethinking Clinical Trials Grand Rounds, Julie Lauffenburger of Harvard Medical School will present on the “Impact of Behavioral Science-Based Electronic Health Record Tools on Deprescribing for Older […]
Iran-linked hackers have disrupted multiple US industrial sites
Iran-linked hackers have successfully targeted and caused disruptions at multiple US oil and gas and water sites in recent weeks, according to a federal advisory released Tuesday and three sources familiar with the investigation.
Viewpoint: FP10 should remain open, excellent and secure
Europe is right to worry about research security. Foreign interference is real. So is the misuse of sensitive knowledge. Universities working in sensitive areas such as AI, quantum, semiconductors and advanced materials cannot afford to ignore the geopolitical environment around them.But Europe is in danger of drawing the wrong conclusion, one that would increase, not reduce, its strategic vulnerabilities.If the EU applies an “EU preference” logic to the next Framework Programme for research and innovation (FP10), it will weaken one of its greatest strategic assets: a research system built on openness, excellence and international collaboration. In the name of security, Europe could end up advancing science more slowly, innovating less effectively and making itself less attractive to global talent and partners in advanced science and technology.That would be a serious mistake.The EU preference included in Article 10 of the proposed European Competitiveness Fund may make sense in some industrial or deployment contexts, but is far harder to justify when applied to collaborative research in advanced science and technology, where excellence and global connectivity are crucial. Research is not procurement. It does not thrive when isolated. It advances through access to the best ideas, the best people, the best facilities and the best data, wherever they are found. This is why FP10 should not simply absorb industrial policy logic by default. Doing so would risk importing instruments that are ill-suited to research and that ultimately increase vulnerability rather than resilience.For universities of science and technology, the issue is especially acute. These institutions sit at the frontier of knowledge and technology creation in the very fields Europe sees as critical for its future competitiveness and resilience. They know better than most that security risks are real. But they also know that openness and security are not opposites. In practice, they have to be made to work together. Research security is not about closing doors. It is about building resilience through collective responsibility, trust, proportionate safeguards and better governance. That is a fundamentally different approach from default restriction.The risks of non-collaborationThe real danger in the current debate is that Europe talks too much about the risks of collaboration and not enough about the risks of non-collaboration. Those risks are strategic too. Cut researchers off from international networks and Europe loses access to knowledge, data, infrastructures and talent. Slow down global collaboration in critical technologies and Europe slows down its own progress on cutting-edge science. Make participation rules unpredictable and Europe weakens its attractiveness to researchers and investors alike.In other words, over-restricting collaboration will create strategic vulnerabilities, particularly in advanced science and technologies.This point is often underestimated in policy discussions that frame openness mainly as a value to be defended. Europe’s scientific strength, technological development and long-term competitiveness depend on remaining connected to the best research ecosystems in the world. For a continent that wants to accelerate deep tech, strengthen industrial capacity and reduce strategic dependencies, weakening the excellence base would be self-defeating. That does not mean ignoring risk. Quite the opposite. Universities are already strengthening due diligence, internal governance, awareness-raising, screening procedures and compliance support. Across Europe, institutions are working to manage risks linked to foreign interference, sanctions, export controls and the misuse of research. The right response is not complacency. It is better risk management. But that means targeted, evidence-based and proportionate measures, not blunt top-down restrictions with wide spillover effects. In the daily reality of universities, openness and restriction often coexist. The real challenge is how to apply safeguards without sliding into securitisation that damages academic freedom, open science and international cooperation. Restrict partners, not nationsMore restrictive treatment of collaborators from European Economic Area members Iceland, Liechtenstein and Norway, or from Switzerland and the UK, is strategically very difficult to justify. These are deeply embedded partners in Europe’s research and innovation ecosystem. Beyond that, Europe should still resist default exclusion and instead rely on case-by-case assessment. The relevant question is not nationality in the abstract. It is the actual risk profile of a collaboration: the institution, the affiliations, the field, the knowledge involved, the intended use and the safeguards available. Screening should focus on institutions and affiliations rather than nationality alone. Related articlesParliament ‘misreads’ link between Horizon Europe and ECF, Commission official saysFrustration grows at governance gap in next Horizon EuropeIf EU preference logic is imported into research without careful calibration, the likely result is a chilling effect. Researchers may step back from legitimate and beneficial collaboration, even where risks are manageable. International partners may see Europe as less predictable. And Europe may end up undermining the very excellence base it needs to compete, scale up and lead in strategic technologies, thereby increasing its dependence on others.FP10 should do the opposite. It should remain open by default, with restrictions used only exceptionally, and then on the basis of clear evidence. It should integrate research security into open science and research integrity frameworks, not set them against each other. And it should recognise that academic freedom, scientific excellence and responsible international collaboration are not obstacles to Europe’s security, they are part of it. Europe needs stronger tools to protect itself. But it also needs the discipline to avoid measures that would weaken it and increase its strategic vulnerabilities in the process. In FP10, that means staying open, excellent and secure.Louise Drogoul is senior advisor for innovation and sustainability at the Cesaer university association.
Immunic COO highlights the importance of science-led innovation to mark World Health Day
Immunic Inc (NASDAQ:IMUX, FRA:10VA) chief operating officer Jason Tardio talked with Proactive's Stephen Gunnion about the importance of science-led innovation in tackling neurological diseases, particularly multiple sclerosis, on World Health Day 2026. Tardio highlighted that the biotech industry is fundamentally grounded in scientific research and data, noting that “everything we do is rooted in science.” He explained that Immunic is focused on developing innovative therapies designed to improve patient outcomes and address significant unmet medical needs. The discussion centred on multiple sclerosis (MS), a complex neurological disease that continues to present challenges despite decades of progress. Tardio pointed out that while advancements have been made, “the disease is not solved for,” with many patients still experiencing disability progression and requiring safer, more tolerable treatments. He emphasised the urgent need for innovation, particularly in progressive forms of MS where treatment options remain extremely limited. Immunic’s lead asset, vidofludimus calcium, is being developed as a novel approach aimed at addressing the full spectrum of the disease. Tardio also reinforced the broader mission of the healthcare and biotech sectors, stating that the ultimate goal is to help individuals “live a better quality of life” and “a healthier life longer.” Watch the full interview to learn more about Immunic’s approach to advancing MS treatment through science. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #Immunic #MultipleSclerosis #BiotechInnovation #Healthcare #MSResearch #DrugDevelopment #ClinicalTrials #Neurology #WorldHealthDay #ScienceDriven #VidofludimusCalcium #PharmaNews #BiotechNews
AI finds drug safety signals in clinical notes
Large language models were tested on cancer patient notes from two academic medical centers and seven drug trials.
iPhone Fold Enters Trial Production Phase Ahead of 2026 Launch
Apple partner Foxconn has started trial production on the iPhone Fold, according to Chinese leaker Instant Digital. Trial production comes before mass production, which Apple plans to start in July as long as no issues come up during the earlier testing stage. So far, Apple remains on track to launch the iPhone Fold in 2026, though the latest rumors suggest that it's not going to come out in September. Instead, it could launch sometime after the iPhone 18 Pro, debuting as late as December.
Lil Nas X Granted Mental Health Diversion in LAPD Battery Case
Lil Nas X had will see his felony police battery charges dismissed if he completes a two-year mental health diversion program, a judge said Monday.
Federal Agency Unveils Three Potential Osteoarthritis Treatments
With funding from ARPA-H, three teams of researchers have regrown bone and cartilage, even entire knees, in animal studies. Human trials are not far off.
‘GMA’: Melissa Gilbert Fiercely Defends Timothy Busfield Through Tears
Busfield awaits trial on charges of sexual abuse against minors.
‘GMA’: Melissa Gilbert Fiercely Defends Timothy Busfield Through Tears
Busfield awaits trial on charges of sexual abuse against minors.
‘GMA’: Melissa Gilbert Fiercely Defends Timothy Busfield Through Tears
Busfield awaits trial on charges of sexual abuse against minors.
UnitedHealth makes a bet on AI. What does it mean for us?
A hep B trial raises ethical questions, the peptide hype, and more Morning Rounds news
Institute of Industrial Science, The University of Tokyo and George Mason University scientists mine past air temperature forecasts, lower cost with greater subseasonal prediction accuracy
Researchers at Institute of Industrial Science, The University of Tokyo and George Mason University‘s College of Science have developed a new method that improves air temperature forecasts one to five weeks in advance—without requiring additional model simulations.
Jeanine Pirro’s office keeps prosecuting Trump’s foes. Some DC jurors are pushing back
The DC US attorney’s office under Jeanine Pirro has had an unusually low win rate in trials in Washington’s federal district court this year, at a moment when the White House has been clamoring for President Donald Trump’s Justice Department to deliver on prosecutions.
AI breakthrough cuts energy use by 100x while boosting accuracy
AI is consuming staggering amounts of energy—already over 10% of U.S. electricity—and the demand is only accelerating. Now, researchers have unveiled a radically more efficient approach that could slash AI energy use by up to 100× while actually improving accuracy. By combining neural networks with human-like symbolic reasoning, their system helps robots think more logically instead of relying on brute-force trial and error.
A Look At Brookfield Business Partners (TSX:BBUC) Valuation After Its Recent 3.6% One Day Move
What Brookfield Business Partners’ Numbers Tell You Right Now Brookfield Business Partners (TSX:BBUC) is getting attention after a recent move in its units, with a 1 day return of 3.6% and a last close of CA$48.00 catching many investors’ eye. The partnership runs a private equity model through business services, infrastructure services, construction, energy, and industrials. It reported CA$27,457.0 million in revenue and a net loss of $26.0 million in its latest figures. For investors...
Mangat Group bets $250M on West Valley small business spaces
A developer plans to invest $250 million in small industrial units, targeting small business squeezed out by large warehouses.
Artemis II astronauts are also having Microsoft Outlook issues
IT problems aren't just a terrestrial matter.
OMRON Healthcare and UCSF Launch AFib Trial
Study Will Explore Early Detection of Atrial Fibrillation to Reduce Stroke and Heart Failure Risk Through Home Blood Pressure Monitoring KYOTO, JAPAN - April 3, 2026 (NEWMEDIAWIRE) - OMRON Healthcare Co., Ltd. today announced the launch of a randomiz...
Judge tosses Blake Lively’s sexual harassment claims against Justin Baldoni one month before trial
A federal judge tossed out all of Blake Lively’s legal claims against her “It Ends With Us” director Justin Baldoni, leaving only three claims against other defendants to be addressed at the upcoming trial.
Iterative Health, US Heart & Vascular Partner to Advance Community-Based Cardiovascular Research
April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance research through community-based innovation in cardiovascular care. "Clinical research is one of the most powerful ways we expand access, improve patient outcomes, and shape the future of cardiovascular care," said Robbie Allen, chief executive officer of US Heart & Vascular. "By partnering with Iterative Health, we are strengthening our ability to bring innovative therapies directly into the communities we serve. This collaboration ensures our physicians and patients have access to leading-edge trials while allowing US Heart & Vascular to remain focused on delivering exceptional, physician-led care." Under the agreement, USHV research sites will join Iterative Health’s global site network, which now spans over 100 sites across three continents. The companies share a commitment to advancing clinical research as a driver of care innovation, and this collaboration represents a major milestone for both organizations, strengthening USHV's leadership in community-based cardiovascular research and expanding Iterative Health's multispecialty focus beyond GI, hepatology, and obesity into cardiology. USHV clinical research sites will gain access to Iterative Health's centralized operational backbone, providing end-to-end support across clinical research operations, services, business development, technology innovation, and corporate functions. The strategic partnership reduces operational complexity and unlocks growth potential for USHV research sites while enabling all USHV physicians to expand access to cutting-edge therapies to the thousands of patients they serve annually. "Innovation in cardiovascular medicine shouldn't be limited to a few academic centers," said Thomas Waggoner, DO, MD, RPVI, FACC, FSCAI, FSVM, RPVI, Structural Cardiologist and Medical Director for Clinical Research at Pima Heart & Vascular, and USHV Physician Champion for Clinical Research. "By expanding community-based research across USHV, we're ensuring more patients have access to clinical trials and breakthrough therapies close to home, where trusted relationships with their physicians already exist." This alliance reinforces Iterative Health's standing as the definitive research partner across specialized therapeutic areas, now spanning GI, hepatology, obesity, and cardiovascular care. Trusted by many of the nation's leading provider organizations and biopharma sponsors, Iterative Health's global site network delivers industry-leading trial performance, accelerating life-changing therapies to market at scale. "Entering cardiology through our strategic partnership with US Heart & Vascular is a defining moment for Iterative Health and reflects the strength of our site-serving model," said Jonathan Ng, founder and CEO of Iterative Health. "Together, we are ensuring that thousands of patients have access to the newest available therapies, and that sponsors have a credible, high-performing partner to accelerate cardiovascular trial success." For more information, visit www.iterative.health and https://usheartandvascular.com/.
New weight-loss pill hits the market, promising 'greater flexibility'
FDA approves Foundayo, a once-daily weight loss pill by Lilly. Clinical trials showed adults lost an average of 27.3 pounds on the highest dose, although there are side effects.
Sharing her passion for science
By Danielle Rush Communications Specialist, Indiana University Kokomo Hisako Masuda, Indiana University Kokomo professor of biochemistry, was honored by the Indiana Academy of Science (IAS) as its 2026 Distinguished Scholar. The award is given to an individual who is recognized by the IAS as having an exceptional record of scholarship. Recipients are selected from nominations submitted to its awards committee. “I was surprised,” said Masuda, who joined IU Kokomo’s faculty in 2013. “I feel there are many good scientists in the Academy, so I wasn’t expecting it at all.” Patrick Motl, dean of the School of Sciences, said the Academy recognizes up to one member per year, and that Masuda is the second or third IU Kokomo faculty member to receive the commendation. “Clearly this speaks to the strength of Dr. Masuda’s accomplishments in research and scholarship and that her work stands out amongst her peers in Indiana,” said Motl, who received the award in 2019. “Many of the institutions that participate in the IAS are undergraduate institutions or primarily undergraduate institutions, but even having that caveat, Dr. Masuda has built and maintains a very active research program in her lab, working exclusively with undergraduates. She is passionate about science and can share that passion with her students. To carry on a quality research program with so many students involved in so many projects is truly remarkable and I am glad that the IAS acknowledged that for Dr. Masuda.” The IAS specifically commended her for involving more than 50 undergraduates in her research in bacterial metabolism, genomics, and their phenotypic plasticity at IU Kokomo, and publishing 23 articles with many student co-authors. Masuda’s current work primarily focuses on biodegradation and chemical repurposing of nylon. Using soil bacteria, her lab studies bacterial biodegradation of nylon and other environmental pollutants. She applies principles of green chemistry while developing a method to convert nylon waste into other nontoxic polymers. In collaborative work with health scientists, her lab investigates gut microbiomes of Indiana native birds as well as human subjects in a clinical study. She became interested in converting plastic waste while earning her Ph.D. at Rutgers University, working on methods to remove environmental waste not using chemicals or other intrusive methods. She learned about Nylon 11, which is used in pipes for transferring oil, interior components for cars, catheters, and in other industrial hard plastics. Nylon 11 is nontoxic, she added, so it is safe to include students in the research. “Those are considered to be nonbiodegradable, and have to go to a landfill,” she said. “I thought if we could come up with a way to biodegrade it, that would make some kind of impact.” Eventually, she wants to develop a product that would convert nylon waste to something useful, and to reduce waste and microplastics in the environment. “That would be my goal at some point, that we can make that change, and also make people more aware of their use of plastics,” she said. “I hope students stop to think about what we can do as scientists to address issues currently impacting us.” She appreciates the IAS for its support of scientific research at Indiana institutions, and IU Kokomo and the School of Sciences for providing funding for students to attend the Academy’s annual meeting. She added that IU Kokomo has also supported her research with funding from the School of Sciences and Academic Affairs. “Without that, I couldn’t do my research,” she said. Masuda has also earned a Senior Research Grant from the IAS, IU Kokomo’s Distinguished Research Award, and the IU Kokomo Junior Faculty Annual Research Award. She is a Fellow of the Indiana Academy of Science. Education is KEY at Indiana University Kokomo.
Panoramic Health and West Coast Kidney Institute Launch Concord Cardio-Renal Research Institute to Advance Clinical Trials in Cardio-Renal-Metabolic Disease
/PRNewswire/ -- Panoramic Science, the clinical research division of Panoramic Health, and West Coast Kidney Institute today announced the launch of the...
Alien Messages May Have Reached Earth – Why Haven’t Scientists Found Them?
Detecting extraterrestrial signals may require searching farther and longer than previously expected.
Europe has the resources to contain Russia but lacks the political will
Europe unquestionably possesses the industrial and economic base to outmatch Russia but has yet to demonstrate the unity and political will necessary to contain the Kremlin and stop Putin in Ukraine, writes Oleksiy Zagorodnyuk.
Trump isn't immune from civil claims that his Jan. 6 rally speech incited riot, judge rules
U.S. District Judge Amit Mehta's decision now sets the stage for a possible civil trial.
Brian Ballard testifies he previously warned David Rivera's firm about disclosure concerns with Venezuela work
The prominent lobbyist testified against the ex-Congressman in a trial in South Florida.